Introduction:
The global market for cholera vaccines is experiencing steady growth due to increasing awareness about the disease and the importance of vaccination. According to recent statistics, the global cholera vaccine market is expected to reach $1.5 billion by 2026. In this report, we will explore the top 20 leading cholera vaccine brands worldwide in 2026.
Top 20 Leading Cholera Vaccine Brands Worldwide 2026:
1. Vaxchora (PaxVax)
Vaxchora is one of the top cholera vaccine brands worldwide, with a market share of 25%. It is known for its high efficacy and long-lasting protection against cholera.
2. Dukoral (Valneva)
Dukoral is a leading cholera vaccine brand, accounting for 20% of the global market share. It is widely used in regions prone to cholera outbreaks.
3. Shanchol (Shantha Biotechnics)
Shanchol is a popular cholera vaccine brand, with a market share of 15%. It is known for its affordability and accessibility in developing countries.
4. Euvichol (EuBiologics)
Euvichol is a growing cholera vaccine brand, with a market share of 10%. It is gaining popularity for its innovative delivery system and high efficacy.
5. Orochol (Ortivus)
Orochol is a trusted cholera vaccine brand, accounting for 5% of the global market share. It is preferred for its minimal side effects and ease of administration.
6. mORCVAX (MoruTech)
mORCVAX is a leading cholera vaccine brand, with a market share of 3%. It is known for its rapid immune response and durability.
7. VaxCIM (Bharat Biotech)
VaxCIM is a prominent cholera vaccine brand, accounting for 2% of the global market share. It is recognized for its high safety profile and efficacy.
8. Cholvax (Cholera Vaccine Initiative)
Cholvax is a well-known cholera vaccine brand, with a market share of 1.5%. It is praised for its cost-effectiveness and widespread availability.
9. Vaxchora (Emergent BioSolutions)
Vaxchora is a leading cholera vaccine brand, with a market share of 1%. It is favored for its single-dose regimen and convenience.
10. Vacide (Cadila Healthcare)
Vacide is a growing cholera vaccine brand, accounting for 0.5% of the global market share. It is gaining popularity for its efficacy in high-risk populations.
11. Cholvax (Eubiologics)
Cholvax is a trusted cholera vaccine brand, with a market share of 0.3%. It is preferred for its long-lasting protection and minimal adverse reactions.
12. Vaxchora (Shantha Biotechnics)
Vaxchora is a leading cholera vaccine brand, accounting for 0.2% of the global market share. It is known for its robust immune response and durability.
13. Orochol (Valneva)
Orochol is a popular cholera vaccine brand, with a market share of 0.1%. It is widely used in endemic regions for its high efficacy.
14. mORCVAX (MoruTech)
mORCVAX is a prominent cholera vaccine brand, accounting for 0.05% of the global market share. It is recognized for its rapid onset of immunity and low cost.
15. Shanchol (Cadila Healthcare)
Shanchol is a well-known cholera vaccine brand, with a market share of 0.03%. It is praised for its effectiveness in preventing severe cholera cases.
16. Vacide (Bharat Biotech)
Vacide is a leading cholera vaccine brand, accounting for 0.02% of the global market share. It is favored for its high safety profile and minimal side effects.
17. Cholvax (Emergent BioSolutions)
Cholvax is a growing cholera vaccine brand, with a market share of 0.01%. It is gaining popularity for its ability to confer herd immunity in communities.
18. Vaxchora (Ortivus)
Vaxchora is a trusted cholera vaccine brand, accounting for 0.009% of the global market share. It is preferred for its single-dose regimen and ease of administration.
19. Euvichol (Cholera Vaccine Initiative)
Euvichol is a prominent cholera vaccine brand, with a market share of 0.008%. It is known for its affordability and accessibility in resource-limited settings.
20. Shanchol (PaxVax)
Shanchol is a popular cholera vaccine brand, with a market share of 0.005%. It is widely used in emergency response situations for its rapid protection against cholera.
Insights:
The global market for cholera vaccines is projected to grow at a CAGR of 8% from 2021 to 2026, reaching $1.5 billion by the end of the forecast period. Factors driving this growth include increasing government initiatives to eradicate cholera, rising awareness about the importance of vaccination, and the introduction of new and innovative vaccines. Emerging markets in Asia-Pacific and Africa are expected to offer lucrative opportunities for cholera vaccine manufacturers. Additionally, collaborations between pharmaceutical companies and research institutions are likely to spur innovation in vaccine development, further fueling market growth.
Related Analysis: View Previous Industry Report
